Benzinga's Top Downgrades - BioCryst Pharma (NASDAQ:BCRX), Global X Funds Global X Emerging Markets Great Consumer ETF (ARCA:EMC)

Analysts at Bernstein downgraded

SanDisk Corporation SNDK

from Outperform to Market Perform. SanDisk shares closed at $75.70 on Tuesday. Analysts at JP Morgan downgraded

Lennox International Inc. LII

from Overweight to Neutral. Lennox International shares closed at $134.93 on Tuesday. Goldman Sachs downgraded

Rice Energy Inc RICE

from Buy to Neutral. Rice Energy shares closed at $15.80 on Tuesday. Wells Fargo downgraded

EMC CorporationEMC

from Outperform to Market Perform. EMC shares closed at $25.25 on Tuesday. Analysts at Morgan Stanley downgraded

Metlife Inc MET

from Overweight to Equal-weight. The price target for MetLife has been lowered from $58 to $56. MetLife shares closed at $50.77 on Tuesday. Barclays downgraded

Metaldyne Performance Group Inc MPG

from Overweight to Equal-weight. The price target for Metaldyne Performance is set to $23. Metaldyne Performance shares closed at $22.35 on Tuesday. Analysts at Morgan Stanley downgraded

Oracle CorporationORCL

from Overweight to Equal-weight. The price target for Oracle is set to $45. Oracle shares closed at $39.94 on Tuesday. Bank of America downgraded

BioCryst Pharmaceuticals, Inc. BCRX

from Neutral to Underperform. Biocryst Pharmaceuticals shares closed at $10.21 on Tuesday.

Market News and Data brought to you by Benzinga APIs